Featured News

Oppenheimer on FireEye: Checks Indicate Positive Momentum Intact

Oppenheimer on FireEye: Checks Indicate Positive Momentum Intact

Oppenheimer is reiterating their Outperform rating on shares of FireEye, Inc. (NASDAQ:FEYE) heading into earnings this week.  The analyst noted ” We reiterate our Outperform rating and $35 PT on FEYE shares and believe the set-up into 5/5 earnings remains attractive given: 1) Recent channel checks with 20 VARs indicating at least in-line 1Q16 results; 2) Continued traction of FaaS (billing run rate of[Read More…]

by May 3, 2016
Exxon Mobil Corporation (NYSE:XOM): Most Resilient Cash Generator According to Jefferies

Exxon Mobil Corporation (NYSE:XOM): Most Resilient Cash Generator According to Jefferies

Jefferies issued a note to Exxon Mobil Corporation (NYSE:XOM) investors after the firm posted a solid earnings beat.  The firm noted “EPS of $0.43 beat our estimate of $0.34 on strong earnings in the Chemicals segment. CFFO was $4.8b, which missed our estimate by $1.6b. Despite the miss on our estimate, we believe that XOM has amongst the most resilient cash generation in the[Read More…]

by May 3, 2016
Jefferies on Dow Chemical (DOW) Q1 Model Update

Jefferies on Dow Chemical (DOW) Q1 Model Update

Jefferies issued an update on Dow Chemical Company (NYSE:DOW) this week.  The firm increased their price target to $58 from $54 and are staying with their Hold rating on the shares. In taking a look at estimates as a whole, the brokerage is one of 10 firms in total that have recently weighed in on Dow Chemical Company (The). Wall Street consensus[Read More…]

by May 2, 2016
Jefferies on Viacom (VIAB): Long Term Story In Tact

Jefferies on Viacom (VIAB): Long Term Story In Tact

Following Viacom’s earnings report, Jefferies has noted that management’s remarks indicate that the long-term affiliate story continues to be in tact.  The sale of their stake in Paramount will be a key driver for the stock in Q3.  The analyst stated, “Given deals signed with all major distributors, VIAB has considerable visibility into its long term rate increases – the swing factor[Read More…]

by April 29, 2016
Jefferies on Automatic Data Processing (ADP) Modest Q3 Miss

Jefferies on Automatic Data Processing (ADP) Modest Q3 Miss

In a note sent out to investors this week, Jefferies weighed in on Automatic Data Processing, Inc. (NASDAQ:ADP)’s earnings report.  The firm noted that results came in modestly lower than expectations and they see the valuation as too rich at current levels. “ADP’s Q3 results came in modestly lower than expectations with revenues missing JEFe/Street estimates by ~1%. In the context[Read More…]

by April 29, 2016
Amgen Inc. (NASDAQ:AMGN): Trinity of Price, Volume & Diversification Bodes Positively Near Term According to Leerink

Amgen Inc. (NASDAQ:AMGN): Trinity of Price, Volume & Diversification Bodes Positively Near Term According to Leerink

Leerink has increased their target price on shares of Amgen Inc. citing the trinity of solid Price, Volume & Diversification after the firm beat consensus estimates on the top and bottom lines. “Overall revenue growth was 10% compared to Q1 2015 and flat compared to Q4 2015. The main contributors to growth were Enbrel, Aranesp, Prolia and Kyprolis; the main drag on growth was[Read More…]

by April 29, 2016